Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 M<sup>pro</sup> inhibitors

Tika R. Malla, Anthony Tumber, Tobias John, Lennart Brewitz, Claire Strain‐Damerell, David Owen, Petra Lukacik, H. T. Henry Chan, Pratheesh Maheswaran, E. Salah,

Chemical Communications · 2021 · 50 citations · 17 references

DOIFull text

Open access

Concepts

Abstract

The main viral protease (Mpro) of SARS-CoV-2 is a nucleophilic cysteine hydrolase and a current target for anti-viral chemotherapy. We describe a high-throughput solid phase extraction coupled to mass spectrometry Mpro assay. The results reveal some β-lactams, including penicillin esters, are active site reacting Mpro inhibitors, thus highlighting the potential of acylating agents for Mpro inhibition.

References

17